Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 441

1.

Analysis of the Paternally-Imprinted DLK1-MEG3 and IGF2-H19 Tandem Gene Loci in NT2 Embryonal Carcinoma Cells Identifies DLK1 as a Potential Therapeutic Target.

Sellers ZP, Schneider G, Maj M, Ratajczak MZ.

Stem Cell Rev. 2018 Jul 6. doi: 10.1007/s12015-018-9838-5. [Epub ahead of print]

PMID:
29980981
2.

The Emerging Link Between the Complement Cascade and Purinergic Signaling in Stress Hematopoiesis.

Ratajczak MZ, Adamiak M, Kucia M, Tse W, Ratajczak J, Wiktor-Jedrzejczak W.

Front Immunol. 2018 Jun 5;9:1295. doi: 10.3389/fimmu.2018.01295. eCollection 2018. Review.

3.

A Circadian Rhythm in both Complement Cascade (ComC) Activation and Sphingosine-1-Phosphate (S1P) Levels in Human Peripheral Blood Supports a Role for the ComC-S1P Axis in Circadian Changes in the Number of Stem Cells Circulating in Peripheral Blood.

Budkowska M, Ostrycharz E, Wojtowicz A, Marcinowska Z, Woźniak J, Ratajczak MZ, Dołęgowska B.

Stem Cell Rev. 2018 Jun 17. doi: 10.1007/s12015-018-9836-7. [Epub ahead of print]

PMID:
29911288
4.

Kinin and Purine Signaling Contributes to Neuroblastoma Metastasis.

Ulrich H, Ratajczak MZ, Schneider G, Adinolfi E, Orioli E, Ferrazoli EG, Glaser T, Corrêa-Velloso J, Martins PCM, Coutinho F, Santos APJ, Pillat MM, Sack U, Lameu C.

Front Pharmacol. 2018 May 18;9:500. doi: 10.3389/fphar.2018.00500. eCollection 2018.

5.

Mulhouse Strategy to Expand Ex Vivo Very Small Embryonic Like Stem Cells (VSELs) - Recent Study Published in Stem Cell Reviews and Reports.

Ratajczak MZ.

Stem Cell Rev. 2018 Aug;14(4):461-462. doi: 10.1007/s12015-018-9827-8. No abstract available.

PMID:
29802508
6.

Novel evidence that extracellular nucleotides and purinergic signaling induce innate immunity-mediated mobilization of hematopoietic stem/progenitor cells.

Adamiak M, Bujko K, Cymer M, Plonka M, Glaser T, Kucia M, Ratajczak J, Ulrich H, Abdel-Latif A, Ratajczak MZ.

Leukemia. 2018 Mar 30. doi: 10.1038/s41375-018-0122-0. [Epub ahead of print]

PMID:
29725032
7.

New Hope for Treatment of Duchene Dystrophy by Employing Dystrophin Expressing Chimeric Cells - Studies Published in Stem Cell Reviews and Reports.

Ratajczak MZ.

Stem Cell Rev. 2018 Jun;14(3):295-296. doi: 10.1007/s12015-018-9818-9. No abstract available.

PMID:
29705868
8.

Mobilization of hematopoietic stem cells as a result of innate immunity-mediated sterile inflammation in the bone marrow microenvironment-the involvement of extracellular nucleotides and purinergic signaling.

Ratajczak MZ, Adamiak M, Plonka M, Abdel-Latif A, Ratajczak J.

Leukemia. 2018 May;32(5):1116-1123. doi: 10.1038/s41375-018-0087-z. Epub 2018 Mar 5. Review.

9.

Sterile Inflammation of Brain, due to Activation of Innate Immunity, as a Culprit in Psychiatric Disorders.

Ratajczak MZ, Pedziwiatr D, Cymer M, Kucia M, Kucharska-Mazur J, Samochowiec J.

Front Psychiatry. 2018 Feb 28;9:60. doi: 10.3389/fpsyt.2018.00060. eCollection 2018. Review.

10.

A novel potential role of pituitary gonadotropins in the pathogenesis of human colorectal cancer.

Marlicz W, Poniewierska-Baran A, Rzeszotek S, Bartoszewski R, Skonieczna-Żydecka K, Starzyńska T, Ratajczak MZ.

PLoS One. 2018 Mar 1;13(3):e0189337. doi: 10.1371/journal.pone.0189337. eCollection 2018.

11.

Evaluation of a developmental hierarchy for breast cancer cells to assess risk-based patient selection for targeted treatment.

Bliss SA, Paul S, Pobiarzyn PW, Ayer S, Sinha G, Pant S, Hilton H, Sharma N, Cunha MF, Engelberth DJ, Greco SJ, Bryan M, Kucia MJ, Kakar SS, Ratajczak MZ, Rameshwar P.

Sci Rep. 2018 Jan 10;8(1):367. doi: 10.1038/s41598-017-18834-5.

12.

Novel evidence that pituitary sex hormones regulate migration, adhesion, and proliferation of embryonic stem cells and teratocarcinoma cells.

Sellers ZP, Bujko K, Schneider G, Kucia M, Ratajczak MZ.

Oncol Rep. 2018 Feb;39(2):851-859. doi: 10.3892/or.2017.6108. Epub 2017 Nov 24.

PMID:
29207191
13.

Verrucarin J inhibits ovarian cancer and targets cancer stem cells.

Carter K, Rameshwar P, Ratajczak MZ, Kakar SS.

Oncotarget. 2017 Oct 6;8(54):92743-92756. doi: 10.18632/oncotarget.21574. eCollection 2017 Nov 3.

14.

Extracellular Microvesicles as Game Changers in Better Understanding the Complexity of Cellular Interactions-From Bench to Clinical Applications.

Ratajczak MZ, Ratajczak J.

Am J Med Sci. 2017 Nov;354(5):449-452. doi: 10.1016/j.amjms.2017.06.001. Epub 2017 Jun 8. Review.

15.

HO-1 inhibits migration of leukemic cells.

Ratajczak MZ.

Oncotarget. 2017 Sep 19;8(52):89429-89430. doi: 10.18632/oncotarget.21044. eCollection 2017 Oct 27. No abstract available.

16.

Withaferin A (WFA) inhibits tumor growth and metastasis by targeting ovarian cancer stem cells.

Kakar SS, Parte S, Carter K, Joshua IG, Worth C, Rameshwar P, Ratajczak MZ.

Oncotarget. 2017 Aug 10;8(43):74494-74505. doi: 10.18632/oncotarget.20170. eCollection 2017 Sep 26.

17.

Mannan binding lectin triggers mobilization of hematopoietic stem cells.

Adamiak M, Abdel-Latif A, Ratajczak MZ.

Oncotarget. 2017 Sep 8;8(43):73368-73369. doi: 10.18632/oncotarget.20705. eCollection 2017 Sep 26. No abstract available.

18.

Ovarian Cancer Stem Cells: Unraveling a Germline Connection.

Parte SC, Smolenkov A, Batra SK, Ratajczak MZ, Kakar SS.

Stem Cells Dev. 2017 Dec 15;26(24):1781-1803. doi: 10.1089/scd.2017.0153. Epub 2017 Nov 28.

PMID:
29078734
19.

Looking Back at the Past Year of Stem Cell Reviews and Reports.

Ratajczak MZ.

Stem Cell Rev. 2017 Dec;13(6):703-704. doi: 10.1007/s12015-017-9779-4. No abstract available.

PMID:
29064017
20.

Mobilization studies in mice deficient in sphingosine kinase 2 support a crucial role of the plasma level of sphingosine-1-phosphate in the egress of hematopoietic stem progenitor cells.

Adamiak M, Chelvarajan L, Lynch KR, Santos WL, Abdel-Latif A, Ratajczak MZ.

Oncotarget. 2017 Jul 24;8(39):65588-65600. doi: 10.18632/oncotarget.19514. eCollection 2017 Sep 12.

21.

Stem cells and mechanisms regulating their trafficking - a new and challenging area of investigation in modern psychiatry.

Ratajczak MZ.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Jan 3;80(Pt A):1-2. doi: 10.1016/j.pnpbp.2017.08.018. No abstract available.

22.

Novel pleiotropic effects of bioactive phospholipids in human lung cancer metastasis.

Schneider G, Sellers ZP, Bujko K, Kakar SS, Kucia M, Ratajczak MZ.

Oncotarget. 2017 Apr 27;8(35):58247-58263. doi: 10.18632/oncotarget.17461. eCollection 2017 Aug 29.

23.

Signaling of the Complement Cleavage Product Anaphylatoxin C5a Through C5aR (CD88) Contributes to Pharmacological Hematopoietic Stem Cell Mobilization.

Bujko K, Rzeszotek S, Hoehlig K, Yan J, Vater A, Ratajczak MZ.

Stem Cell Rev. 2017 Dec;13(6):793-800. doi: 10.1007/s12015-017-9769-6.

24.

Novel View on Umbilical Cord Blood and Maternal Peripheral Blood-an Evidence for an Increase in the Number of Circulating Stem Cells on Both Sides of the Fetal-Maternal Circulation Barrier.

Sielatycka K, Poniewierska-Baran A, Nurek K, Torbé A, Ratajczak MZ.

Stem Cell Rev. 2017 Dec;13(6):774-780. doi: 10.1007/s12015-017-9763-z.

25.

Innate Immunity and Mobilization of Hematopoietic Stem Cells.

Adamiak M, Ratajczak MZ.

Curr Stem Cell Rep. 2017;3(3):172-180. doi: 10.1007/s40778-017-0087-3. Epub 2017 Jul 10. Review.

26.

Stem cells, pluripotency and glial cell markers in peripheral blood of bipolar patients on long-term lithium treatment.

Ferensztajn-Rochowiak E, Kucharska-Mazur J, Tarnowski M, Samochowiec J, Ratajczak MZ, Rybakowski JK.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Jan 3;80(Pt A):28-33. doi: 10.1016/j.pnpbp.2017.06.013. Epub 2017 Jun 16.

PMID:
28625858
27.

Why are hematopoietic stem cells so 'sexy'? on a search for developmental explanation.

Ratajczak MZ.

Leukemia. 2017 Aug;31(8):1671-1677. doi: 10.1038/leu.2017.148. Epub 2017 May 15. Review.

28.

Stem cells and their potential clinical applications in psychiatric disorders.

Ratajczak MZ, Ciechanowicz AK, Kucharska-Mazur J, Samochowiec J.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Jan 3;80(Pt A):3-9. doi: 10.1016/j.pnpbp.2017.04.020. Epub 2017 Apr 20. Review.

PMID:
28435007
29.

Adult stem cells in psychiatric disorders - New discoveries in peripheral blood.

Kucharska-Mazur J, Jabłoński M, Misiak B, Frydecka D, Rybakowski J, Ratajczak MZ, Samochowiec J.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Jan 3;80(Pt A):23-27. doi: 10.1016/j.pnpbp.2017.04.005. Epub 2017 Apr 7. Review.

PMID:
28392482
30.

Of Cytometry, Stem Cells and Fountain of Youth.

Galkowski D, Ratajczak MZ, Kocki J, Darzynkiewicz Z.

Stem Cell Rev. 2017 Aug;13(4):465-481. doi: 10.1007/s12015-017-9733-5. Review.

PMID:
28364326
31.

Prolonged Growth Hormone/Insulin/Insulin-like Growth Factor Nutrient Response Signaling Pathway as a Silent Killer of Stem Cells and a Culprit in Aging.

Ratajczak MZ, Bartke A, Darzynkiewicz Z.

Stem Cell Rev. 2017 Aug;13(4):443-453. doi: 10.1007/s12015-017-9728-2. Review.

32.

Sirt1 Regulates DNA Methylation and Differentiation Potential of Embryonic Stem Cells by Antagonizing Dnmt3l.

Heo J, Lim J, Lee S, Jeong J, Kang H, Kim Y, Kang JW, Yu HY, Jeong EM, Kim K, Kucia M, Waigel SJ, Zacharias W, Chen Y, Kim IG, Ratajczak MZ, Shin DM.

Cell Rep. 2017 Feb 21;18(8):1930-1945. doi: 10.1016/j.celrep.2017.01.074.

33.

Stem Cell Reviews and Reports: New Directions and Developments : A Letter from the Editor-in-Chief.

Ratajczak MZ.

Stem Cell Rev. 2017 Feb;13(1):1. doi: 10.1007/s12015-017-9729-1. No abstract available.

PMID:
28205001
34.

A Novel View of the Adult Stem Cell Compartment From the Perspective of a Quiescent Population of Very Small Embryonic-Like Stem Cells.

Ratajczak MZ, Ratajczak J, Suszynska M, Miller DM, Kucia M, Shin DM.

Circ Res. 2017 Jan 6;120(1):166-178. doi: 10.1161/CIRCRESAHA.116.309362. Review.

35.

Erythropoietin enhances migration of human neuroblastoma cells: in vitro studies and potential therapeutic implications.

Poniewierska-Baran A, Rajewska-Majchrzak J, Ratajczak MZ.

J Cancer Stem Cell Res. 2017;5. pii: e1003. Epub 2017 Apr 27.

36.

Pituitary sex hormones enhance the pro‑metastatic potential of human lung cancer cells by downregulating the intracellular expression of heme oxygenase‑1.

Abdelbaset-Ismail A, Pedziwiatr D, Schneider G, Niklinski J, Charkiewicz R, Moniuszko M, Kucia M, Ratajczak MZ.

Int J Oncol. 2017 Jan;50(1):317-328. doi: 10.3892/ijo.2016.3787. Epub 2016 Dec 2.

37.

Mobilization of Peripheral Blood Stem Cells and Changes in the Concentration of Plasma Factors Influencing their Movement in Patients with Panic Disorder.

Jabłoński M, Mazur JK, Tarnowski M, Dołęgowska B, Pędziwiatr D, Kubiś E, Budkowska M, Sałata D, Wysiecka JP, Kazimierczak A, Reginia A, Ratajczak MZ, Samochowiec J.

Stem Cell Rev. 2017 Apr;13(2):217-225. doi: 10.1007/s12015-016-9700-6.

38.

Stem cells and clinical practice: new advances and challenges at the time of emerging problems with induced pluripotent stem cell therapies.

Ratajczak MZ, Bujko K, Wojakowski W.

Pol Arch Med Wewn. 2016 Nov 10;126(11):879-890. doi: 10.20452/pamw.3644. Epub 2016 Nov 10. Review.

39.

Involvement of BAFF and APRIL in Resistance to Apoptosis of Acute Myeloid Leukemia.

Bolkun L, Grubczak K, Schneider G, Zembko P, Radzikowska U, Singh P, Kloczko J, Ratajczak MZ, Moniuszko M, Eljaszewicz A.

J Cancer. 2016 Sep 30;7(14):1979-1983. eCollection 2016.

40.

Novel evidence that the mannan-binding lectin pathway of complement activation plays a pivotal role in triggering mobilization of hematopoietic stem/progenitor cells by activation of both the complement and coagulation cascades.

Adamiak M, Abdelbaset-Ismail A, Suszynska M, Abdel-Latif A, Ratajczak J, Ratajczak MZ.

Leukemia. 2017 Jan;31(1):262-265. doi: 10.1038/leu.2016.278. Epub 2016 Oct 13. No abstract available.

41.

Extracellular Microvesicles (ExMVs) in Cell to Cell Communication: A Role of Telocytes.

Ratajczak MZ, Ratajczak D, Pedziwiatr D.

Adv Exp Med Biol. 2016;913:41-49. Review.

PMID:
27796879
42.

Effect of colorectal cancer on the number of normal stem cells circulating in peripheral blood.

Marlicz W, Sielatycka K, Serwin K, Kubis E, Tkacz M, Głuszko R, Białek A, Starzyńska T, Ratajczak MZ.

Oncol Rep. 2016 Dec;36(6):3635-3642. doi: 10.3892/or.2016.5179. Epub 2016 Oct 18.

PMID:
27779706
43.

Inducible Nitric Oxide Synthase (iNOS) Is a Novel Negative Regulator of Hematopoietic Stem/Progenitor Cell Trafficking.

Adamiak M, Abdelbaset-Ismail A, Moore JB 4th, Zhao J, Abdel-Latif A, Wysoczynski M, Ratajczak MZ.

Stem Cell Rev. 2017 Feb;13(1):92-103. doi: 10.1007/s12015-016-9693-1.

44.

The Involvment of Hematopoietic-Specific PLC -β2 in Homing and Engraftment of Hematopoietic Stem/Progenitor Cells.

Adamiak M, Suszynska M, Abdel-Latif A, Abdelbaset-Ismail A, Ratajczak J, Ratajczak MZ.

Stem Cell Rev. 2016 Dec;12(6):613-620.

45.

Expression of Cancer Testis Antigens in Colorectal Cancer: New Prognostic and Therapeutic Implications.

Tarnowski M, Czerewaty M, Deskur A, Safranow K, Marlicz W, Urasińska E, Ratajczak MZ, Starzyńska T.

Dis Markers. 2016;2016:1987505. doi: 10.1155/2016/1987505. Epub 2016 Aug 18.

46.

Evidence that vitronectin is a potent migration-enhancing factor for cancer cells chaperoned by fibrinogen: a novel view of the metastasis of cancer cells to low-fibrinogen lymphatics and body cavities.

Schneider G, Bryndza E, Poniewierska-Baran A, Serwin K, Suszynska M, Sellers ZP, Merchant ML, Kaliappan A, Ratajczak J, Kucia M, Garbett NC, Ratajczak MZ.

Oncotarget. 2016 Oct 25;7(43):69829-69843. doi: 10.18632/oncotarget.12003.

47.

Parentally imprinted genes regulate hematopoiesis-new evidence from the Dlk1-Gtl2 locus.

Schneider G, Sellers ZP, Ratajczak MZ.

Stem Cell Investig. 2016 Jul 22;3:29. doi: 10.21037/sci.2016.06.09. eCollection 2016. No abstract available.

48.

Editor's Note.

Ratajczak MZ.

Stem Cell Rev. 2016 Oct;12(5):510. No abstract available.

PMID:
27572687
49.

Toll-like receptor signaling-deficient mice are easy mobilizers: evidence that TLR signaling prevents mobilization of hematopoietic stem/progenitor cells in HO-1-dependent manner.

Adamiak M, Abdelbaset-Ismail A, Kucia M, Ratajczak J, Ratajczak MZ.

Leukemia. 2016 Dec;30(12):2416-2419. doi: 10.1038/leu.2016.236. Epub 2016 Aug 18. No abstract available.

50.

Does it make sense to target one tumor cell chemotactic factor or its receptor when several chemotactic axes are involved in metastasis of the same cancer?

Ratajczak MZ, Suszynska M, Kucia M.

Clin Transl Med. 2016 Dec;5(1):28. doi: 10.1186/s40169-016-0113-6. Epub 2016 Aug 10. Review.

Supplemental Content

Loading ...
Support Center